These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 3838409)

  • 1. Molsidomine in the treatment of acute heart failure.
    Drajer S; Vazquez A; Cercós H; Torres H; Cohn JL; Romero N; Faerman G; Soifer S; Nijensohn CM
    Am Heart J; 1985 Mar; 109(3 Pt 2):712-5. PubMed ID: 3838409
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hemodynamic effects of molsidomine in patients with heart failure following acute myocardial infarction.
    Cantelli I; Lolli C; Brunelli A; Bracchetti D
    Am Heart J; 1985 Mar; 109(3 Pt 2):716-9. PubMed ID: 3838410
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Haemodynamic effects of oral molsidomine in pump failure complicating myocardial infarction.
    Drajer S; Cercós H; Torres H; Vazquez A; Cohn JL; Romero N; Faerman G; Soifer S; Nijensohn CM
    Eur J Clin Pharmacol; 1984; 27(4):419-22. PubMed ID: 6549166
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of molsidomine on hemodynamics and blood gases in acute myocardial infarction with left heart failure.
    Renard M; Jacobs P; Liebens I; Friart A; Bernard R
    Am Heart J; 1985 Mar; 109(3 Pt 2):720-2. PubMed ID: 3919551
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hemodynamic effects of molsidomine in patients with acute myocardial infarction.
    Reifart N; Neidl K; Kaltenbach M; Bussmann WD
    Am Heart J; 1985 Mar; 109(3 Pt 2):708-12. PubMed ID: 3919550
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined digoxin-molsidomine therapy in congestive heart failure following acute myocardial infarction.
    Cantelli I; Parchi C; Palmieri M; Brunelli A; Sangiorgio P; Bracchetti D
    J Cardiovasc Pharmacol; 1986; 8(3):491-9. PubMed ID: 2425163
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term clinical and hemodynamic results of molsidomine treatment in patients with refractory heart failure.
    Acar J; Kulas A; Escudier B
    Am Heart J; 1985 Mar; 109(3 Pt 2):685-7. PubMed ID: 3883737
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The influence of molsidomine on the hemodynamics of patients with chronic heart failure at rest and during exercise.
    Larbig DT; Milstrey HR; Nasse H; Kahle T
    Am Heart J; 1985 Mar; 109(3 Pt 2):688-90. PubMed ID: 3883738
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical and hemodynamic effects of the new dilator drug molsidomine.
    Malcolm AD
    Am Heart J; 1985 Mar; 109(3 Pt 2):674-7. PubMed ID: 3883734
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effect of molsidomine on hemodynamics and myocardial ischemia in patients with acute myocardial infarction (author's transl)].
    Bussmann WD; Neidl K; Kaltenbach M
    Klin Wochenschr; 1982 Jan; 60(2):77-85. PubMed ID: 6896077
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical study of the preparation korvatone].
    Charchoglian RA; Esin NN; Belozerov GE
    Sov Med; 1982; (5):15-8. PubMed ID: 7051350
    [No Abstract]   [Full Text] [Related]  

  • 12. Effects of molsidomine on left ventricular dimensions and cardiac function in patients with chronic heart failure.
    Berkenboom GM; Sobolski JC; Vandermoten PP; Stoupel EE; Degre SG
    Am Heart J; 1985 Mar; 109(3 Pt 2):691-3. PubMed ID: 3838405
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hemodynamic effects of molsidomine vasodilatory therapy in acute myocardial infarction.
    Aptecar M; Otero y Garzon CA; Vasquez A; Varini S; Collia L; Esteguy A; Caruso S
    Am Heart J; 1981 Apr; 101(4):369-73. PubMed ID: 6894215
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of molsidomine and dopamine infusion on the size of canine experimental myocardial infarct.
    Fiedler VB; Buchheim S; Göbel H; Nitz RE
    Naunyn Schmiedebergs Arch Pharmacol; 1982 Dec; 321(4):314-20. PubMed ID: 6897743
    [No Abstract]   [Full Text] [Related]  

  • 15. Hemodynamic and metabolic effects of vasodilator therapy for heart failure in acute myocardial infarction.
    Kodama K; Koretsune Y; Nanto S; Taniura K
    Jpn Circ J; 1984 Apr; 48(4):380-7. PubMed ID: 6425527
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Hemodynamic effects of molsidomine in chronic congestive heart failure].
    Humar F; Maras P; Musitelli G; Camerini F
    G Ital Cardiol; 1986 May; 16(5):427-32. PubMed ID: 3755413
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pharmacological basis of therapy with molsidomine].
    Bassenge E
    Herz; 1982 Oct; 7(5):296-306. PubMed ID: 6897544
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hemodynamic changes produced by molsidomine in patients with congestive myocardiopathy.
    Otero F; Fernández Berges DJ; Milei J; Agejas R; Vázquez A; Pautasso E
    Acta Cardiol; 1984; 39(5):353-63. PubMed ID: 6334953
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Long-term clinical and hemodynamic results of the treatment of refractory cardiac failure with molsidomine].
    Kulas A; Escudier B; Hannachi N; Kolski H; Witchitz S; Acar J
    Arch Mal Coeur Vaiss; 1984 Jan; 77(1):92-9. PubMed ID: 6422898
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effectiveness of molsidomine in the long-term treatment of exertional angina pectoris and chronic congestive heart failure.
    Rudolph W; Dirschinger J
    Am Heart J; 1985 Mar; 109(3 Pt 2):670-4. PubMed ID: 3883733
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.